Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

news

News
Telemedical Care Program Insignificant for Patients With Major Mood Disorders
07/20/2021
Telemedicine care for patients with schizophrenia and bipolar disorder suffering from reduced quality of life is not a significant treatment concept, according to a recent trial published in BMC Psychiatry.
Telemedicine care for patients with schizophrenia and bipolar disorder suffering from reduced quality of life is not a significant treatment concept, according to a recent trial published in BMC Psychiatry.
Telemedicine care for patients...
07/20/2021
Psych Congress Network
News
Neural Connections Boosted by Single Dose of Psilocybin
07/19/2021

Tom Valentino, Senior Editor

Tom Valentino, Senior Editor
A single dose of psilocybin given to mice produced an immediate and long-lasting increase in connections between neurons in the brain in a recent study conducted by researchers at Yale University.
A single dose of psilocybin given to mice produced an immediate and long-lasting increase in connections between neurons in the brain in a recent study conducted by researchers at Yale University.
A single dose of psilocybin...
07/19/2021
Psych Congress Network
News
GlyT1 Inhibitor Improves Cognition in Patients with Schizophrenia in Phase 2 Trial
07/09/2021
Three months of daily, add-on treatment with the oral glycine transporter-1 (GlyT1) inhibitor BI 425809 improved cognition in patients with schizophrenia.
Three months of daily, add-on treatment with the oral glycine transporter-1 (GlyT1) inhibitor BI 425809 improved cognition in patients with schizophrenia.
Three months of daily, add-on...
07/09/2021
Psych Congress Network
News
Telemedical Care Program Insignificant for Patients with Certain Mental Health Disorders
07/01/2021
Telemedicine care for patients with schizophrenia and bipolar disorder suffering from reduced quality of life is not a significant treatment concept, according to a recent trial published in BMC Psychiatry.
Telemedicine care for patients with schizophrenia and bipolar disorder suffering from reduced quality of life is not a significant treatment concept, according to a recent trial published in BMC Psychiatry.
Telemedicine care for patients...
07/01/2021
Psych Congress Network
News
Reduced Antipsychotic Doses During Schizophrenia Maintenance Increase Relapse Risk
06/29/2021
Lowering an antipsychotic dose below the standard range recommended for acute stabilization appears to increase relapse risk and all-cause discontinuation during maintenance treatment in multi-episode schizophrenia.
Lowering an antipsychotic dose below the standard range recommended for acute stabilization appears to increase relapse risk and all-cause discontinuation during maintenance treatment in multi-episode schizophrenia.
Lowering an antipsychotic dose...
06/29/2021
Psych Congress Network
News
Anxiety Symptoms Reported by COVID-19 Healthcare Workers in Survey
06/24/2021
COVID-19 healthcare workers report elevated levels of anxiety symptoms.
COVID-19 healthcare workers report elevated levels of anxiety symptoms.
COVID-19 healthcare workers...
06/24/2021
Psych Congress Network
News
Correctly Diagnosing Bipolar Disorder
06/23/2021
Accurately diagnosing bipolar disorder goes beyond questionnaires and other screeners.
Accurately diagnosing bipolar disorder goes beyond questionnaires and other screeners.
Accurately diagnosing bipolar...
06/23/2021
Psych Congress Network
News
Anticholinergic Medication Associated With Cognitive Impairment in Patients With Schizophrenia
06/23/2021
Cognitive impairments are associated with commonly prescribed psychotropic medications with anticholinergic properties for patients with schizophrenia, according to new research.
Cognitive impairments are associated with commonly prescribed psychotropic medications with anticholinergic properties for patients with schizophrenia, according to new research.
Cognitive impairments are...
06/23/2021
Psych Congress Network
News
Post Partum Risk Linked With Altered Brain Connectivity
06/14/2021
Women at risk of postpartum showed altered brain connectivity in networks associated with goal-directed behavior compared with healthy women, according to a study.
Women at risk of postpartum showed altered brain connectivity in networks associated with goal-directed behavior compared with healthy women, according to a study.
Women at risk of postpartum...
06/14/2021
Psych Congress Network
News
Oral Dissolving Film Rapidly Eases Acute Agitation in Patients with Schizophrenia
05/11/2021
An oral dissolving film for sublingual or buccal administration of dexmedetomidine was effective and well-tolerated for the rapid treatment of acute agitation in patients with schizophrenia, according to a poster presented at the 2021 APA...
An oral dissolving film for sublingual or buccal administration of dexmedetomidine was effective and well-tolerated for the rapid treatment of acute agitation in patients with schizophrenia, according to a poster presented at the 2021 APA...
An oral dissolving film for...
05/11/2021
Psych Congress Network

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use